278 related articles for article (PubMed ID: 28505395)
1. Claudin peptidomimetics modulate tissue barriers for enhanced drug delivery.
Dithmer S; Staat C; Müller C; Ku MC; Pohlmann A; Niendorf T; Gehne N; Fallier-Becker P; Kittel Á; Walter FR; Veszelka S; Deli MA; Blasig R; Haseloff RF; Blasig IE; Winkler L
Ann N Y Acad Sci; 2017 Jun; 1397(1):169-184. PubMed ID: 28505395
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of short-chain alkylglycerols on blood-brain barrier properties of cultured brain endothelial cells.
Hülper P; Veszelka S; Walter FR; Wolburg H; Fallier-Becker P; Piontek J; Blasig IE; Lakomek M; Kugler W; Deli MA
Br J Pharmacol; 2013 Aug; 169(7):1561-73. PubMed ID: 23617601
[TBL] [Abstract][Full Text] [Related]
3. Sodium caprate transiently opens claudin-5-containing barriers at tight junctions of epithelial and endothelial cells.
Del Vecchio G; Tscheik C; Tenz K; Helms HC; Winkler L; Blasig R; Blasig IE
Mol Pharm; 2012 Sep; 9(9):2523-33. PubMed ID: 22827574
[TBL] [Abstract][Full Text] [Related]
4. Reversible opening of the blood-brain barrier by claudin-5-binding variants of Clostridium perfringens enterotoxin's claudin-binding domain.
Neuhaus W; Piontek A; Protze J; Eichner M; Mahringer A; Subileau EA; Lee IM; Schulzke JD; Krause G; Piontek J
Biomaterials; 2018 Apr; 161():129-143. PubMed ID: 29421550
[TBL] [Abstract][Full Text] [Related]
5. Mode of action of claudin peptidomimetics in the transient opening of cellular tight junction barriers.
Staat C; Coisne C; Dabrowski S; Stamatovic SM; Andjelkovic AV; Wolburg H; Engelhardt B; Blasig IE
Biomaterials; 2015 Jun; 54():9-20. PubMed ID: 25907035
[TBL] [Abstract][Full Text] [Related]
6. Reversible Opening of Intercellular Junctions of Intestinal Epithelial and Brain Endothelial Cells With Tight Junction Modulator Peptides.
Bocsik A; Walter FR; Gyebrovszki A; Fülöp L; Blasig I; Dabrowski S; Ötvös F; Tóth A; Rákhely G; Veszelka S; Vastag M; Szabó-Révész P; Deli MA
J Pharm Sci; 2016 Feb; 105(2):754-765. PubMed ID: 26869428
[TBL] [Abstract][Full Text] [Related]
7. Polar and charged extracellular residues conserved among barrier-forming claudins contribute to tight junction strand formation.
Piontek A; Rossa J; Protze J; Wolburg H; Hempel C; Günzel D; Krause G; Piontek J
Ann N Y Acad Sci; 2017 Jun; 1397(1):143-156. PubMed ID: 28415153
[TBL] [Abstract][Full Text] [Related]
8. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells.
Zhu H; Wang Z; Xing Y; Gao Y; Ma T; Lou L; Lou J; Gao Y; Wang S; Wang Y
J Ethnopharmacol; 2012 Jun; 141(2):714-20. PubMed ID: 21920425
[TBL] [Abstract][Full Text] [Related]
9. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
10. Astrocyte mediated modulation of blood-brain barrier permeability does not correlate with a loss of tight junction proteins from the cellular contacts.
Hamm S; Dehouck B; Kraus J; Wolburg-Buchholz K; Wolburg H; Risau W; Cecchelli R; Engelhardt B; Dehouck MP
Cell Tissue Res; 2004 Feb; 315(2):157-66. PubMed ID: 14615934
[TBL] [Abstract][Full Text] [Related]
11. Dehydroepiandrosterone sulfate augments blood-brain barrier and tight junction protein expression in brain endothelial cells.
Papadopoulos D; Scheiner-Bobis G
Biochim Biophys Acta Mol Cell Res; 2017 Aug; 1864(8):1382-1392. PubMed ID: 28495656
[TBL] [Abstract][Full Text] [Related]
12. X-ray irradiation induces disruption of the blood-brain barrier with localized changes in claudin-5 and activation of microglia in the mouse brain.
Yoshida Y; Sejimo Y; Kurachi M; Ishizaki Y; Nakano T; Takahashi A
Neurochem Int; 2018 Oct; 119():199-206. PubMed ID: 29545059
[TBL] [Abstract][Full Text] [Related]
13. A peptidomimetic tight junction modulator to improve regional analgesia.
Zwanziger D; Hackel D; Staat C; Böcker A; Brack A; Beyermann M; Rittner H; Blasig IE
Mol Pharm; 2012 Jun; 9(6):1785-94. PubMed ID: 22524793
[TBL] [Abstract][Full Text] [Related]
14. Claudin-5 binder enhances focused ultrasound-mediated opening in an
Chen L; Sutharsan R; Lee JL; Cruz E; Asnicar B; Palliyaguru T; Wasielewska JM; Gaudin A; Song J; Leinenga G; Götz J
Theranostics; 2022; 12(5):1952-1970. PubMed ID: 35265192
[No Abstract] [Full Text] [Related]
15. Gold Nanoparticles Increase Endothelial Paracellular Permeability by Altering Components of Endothelial Tight Junctions, and Increase Blood-Brain Barrier Permeability in Mice.
Li CH; Shyu MK; Jhan C; Cheng YW; Tsai CH; Liu CW; Lee CC; Chen RM; Kang JJ
Toxicol Sci; 2015 Nov; 148(1):192-203. PubMed ID: 26272951
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells.
András IE; Pu H; Deli MA; Nath A; Hennig B; Toborek M
J Neurosci Res; 2003 Oct; 74(2):255-65. PubMed ID: 14515355
[TBL] [Abstract][Full Text] [Related]
17. Functional effectiveness of the blood-brain barrier to small water-soluble molecules in developing and adult opossum (Monodelphis domestica).
Ek CJ; Dziegielewska KM; Stolp H; Saunders NR
J Comp Neurol; 2006 May; 496(1):13-26. PubMed ID: 16528724
[TBL] [Abstract][Full Text] [Related]
18. A face-to-face comparison of claudin-5 transduced human brain endothelial (hCMEC/D3) cells with porcine brain endothelial cells as blood-brain barrier models for drug transport studies.
Gericke B; Römermann K; Noack A; Noack S; Kronenberg J; Blasig IE; Löscher W
Fluids Barriers CNS; 2020 Aug; 17(1):53. PubMed ID: 32843059
[TBL] [Abstract][Full Text] [Related]
19. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice.
Nitta T; Hata M; Gotoh S; Seo Y; Sasaki H; Hashimoto N; Furuse M; Tsukita S
J Cell Biol; 2003 May; 161(3):653-60. PubMed ID: 12743111
[TBL] [Abstract][Full Text] [Related]
20. Claudin-5: A Pharmacological Target to Modify the Permeability of the Blood-Brain Barrier.
Hashimoto Y; Campbell M; Tachibana K; Okada Y; Kondoh M
Biol Pharm Bull; 2021; 44(10):1380-1390. PubMed ID: 34602546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
